ACT CAPITAL MANAGEMENT, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$3,652,000
-23.2%
110,500
-18.1%
5.04%
-24.2%
Q2 2022$4,753,000
-48.6%
135,000
-32.8%
6.65%
-32.0%
Q1 2022$9,244,000
-33.8%
201,000
-4.5%
9.78%
-3.1%
Q4 2021$13,956,000
+15.2%
210,500
+8.5%
10.09%
+60.7%
Q3 2021$12,111,000
-29.9%
194,000
-7.0%
6.28%
-29.3%
Q2 2021$17,277,000208,6008.88%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders